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Abstract 
The reaction of complex [Pt(Me)(DMSO)(pbz)], 1, (pbz = 2-(2-pyridyl)benzimidazolate) with 
[PtMe(Cl)(DMSO)2], B, followed by addition of bis(diphenylphosphino)acetylene (dppac), 
gave the novel tetranuclear platinum complex [Pt4Me4(µ-dppac)2(pbz)2Cl2], 2, bearing both the 
pbz and dppac ligands. In this structure, the pbz ligands act as both chelating and bridging to 
stabilize the tetraplatinum framework. The tetranuclear Pt(II) complex was fully characterized 
by NMR spectroscopy, X-ray crystallography and mass spectrometry and its electronic 
structure was investigated and supported by DFT calculations.   
 
Introduction 
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The construction of multinuclear metal assemblies has been a growing area of research during 
the past decade.1 Developments based on the use of different ligands as the building unit for 
the synthesis of compounds have been reported for binuclear Pt complexes,2 although to the of 
our knowledge, tetranuclear complexes have been rarely prepared.3 
Wilson and Lippard reported4 a tetranuclear platinum complex in which two acetate-
bridged diplatinum(III) units are connected by two bridging amido ligands (I, Chart 1). The 
syntheses of tetranuclear platinum complexes in which the metal centers are supported by 
phosphido ligands have been reported by Forniés and coworkers (II, Chart 1).5 Stang and Cao 
reported6 the preparation and characterization, via self-assembly, of platinum- and palladium-
based cationic, tetranuclear, macrocyclic complexes (III, Chart 1). In these complexes, 4,4′-
bipyridine acts as spacer ligand between Pt centers. Youngs and his coworkers also reported7 
the synthesis of tetraplatinum square heterocycle which had large cavities and in which the 
rings were composed of only platinum and butadiyne fragments (IV, Chart 1). They used 
chelating phosphines in order to enforce the required cis geometry at the platinum atom. Yam 
et. al.8 synthesized a V-shape luminescent tetranuclear platinum(II) alkynyl complex (V, Chart 
1) and its electrochemical behavior was studied by cyclic voltammetry. Also, very recently, a 
tetranuclear Pt(II) compound using the 1,2,3-tetrazolate as a building block (VI, Chart 1) is 
reported9 in which all triazolate nitrogen atoms are coordinated to 3 different Pt(II) ions. Casas 
and his coworker synthesized10 a tetranuclear platinum(II)-platinum(IV) mixed-valence 
complexes by addition of the stoicheiometric amount of a Pt(II) reagent [cis-[Pt(C6F5)2(thf)2] 
to some binuclear platinum(IV) complexes (VII, Chart 1). 
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Chart 1. Examples of some tetraplatinum complexes 
 
On the other hand, cyclometalated complexes have attracted attention because of their 
several applications in science.11 Of particular interest are cycloplatinated complexes bearing 
strong field ligands such as benzo[h]quinolinate (bhq) and 2-phenylpyridinate (ppy).12 The 
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cycloplatinated(II) compounds with the [Pt(C^N)R] moiety (C^N= cyclometalated ligand and 
R= alkyl, aryl or halide) are very attractive due to their ease of preparation through C-H 
activation of cyclometalated ligands like Hppy or Hbhq with a suitable Pt(II) precursor 
complex preparation.12c-f, 13 Earlier we studied the reaction of the double rollover 
cycloplatinated(II) complex [Pt2(µ-bpy-2H)(Me)2(k1-dppm)2], bpy= 2,2′-bipyridine, (in which 
each metallic center bears a monodentate dppm ligand) with the known monomeric 
cycloplatinated (II) complex [Pt(Me)(bhq)(SMe2)] in a 1:2 molar ratio, which results in the 
unsymmetrical tetranuclear complex [{(bhq)(Me)Pt(µ-dppm)Pt(Me)}2(µ-bpy-2H)] (VIII, 
Chart 1).13b  
  The 2-(2-pyridyl)benzimidazole (Hpbz) ligand normally acts as an anionic N^N 
bidentate ligand through N-H bond activation of the imidazole unit (instead of C‒H activation 
in Hppy and Hbhq ligands).14 Hpbz derivatives have been also used as ‘bipyridine analogues’ 
in some complexes with metal centers such as Cu(I,II),15 Zn(II),16 Ru(II),17 Os(II),18 and 
Re(I).19 The ease of synthesis and the commercial availability of Hpbz are the factors that make 
this an attractive ligand. Although there are many reports on preparation of metal complexes 
in which the pbz acts as N^N bidentate ligand, the complexes bearing this ligand as a bridging 
ligand between two metal centers have not been explored. 
Although the ability of the biphosphine ligands to form polynuclear metal complexes, 
in which the metal centers are supported by these bridging ligands, has produced a very rich 
and interesting chemistry,13c, 20 best of our knowledge, there is no report on using 2-(2-pyridyl)-
benzimidazole where it can concurrently act as a chelating and bridging ligand.  These, together 
with our current interest in the design and synthesis of organoplatinum(II) complexes21 have 
prompted us to exploit the 2-(2-pyridyl)-benzimidazole and bis(diphenylphosphino)acetylene 
(dppac) units as the backbone for the construction of a cyclic tetrplatinum(II) complexes. In 
fact, an attempt has been made to synthesize an interesting tetranuclear organoplatinum(II) 
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complex in which, for the first time, pbz ligands act as both chelating and bridging to stabilize 
the tetraplatinum framework. In this complex dppac ligands are also located as bridging ligands 
between Pt(II) centers. The electronic structure of this complex, supported by theoretical 
calculations, is also investigated. 
 
Experimental section 
General remarks 
 The 1H and 31P NMR spectra were recorded in CDCl3 solutions on a Bruker Avance 
DPX 400 MHz spectrometer using TMS (1H) and H3PO4 (31P) as references. All chemical shifts 
and coupling constants are in ppm and Hz, respectively. Microanalyses were performed using 
a Thermo Finnigan Flash EA-1112 CHNSO rapid elemental analyzer and melting points were 
recorded on a Buchi 530 apparatus. UV-vis absorption spectra were recorded on a PerkinElmer 
Lambda 25 spectrophotometer using a cuvette with a path length of 1 cm and/or 1 mm. The 
complexes [Pt(Me)2(DMSO)2], A,22 and [Pt(Me)(DMSO)(pbz)], 1,23 were prepared by the 
literature method. Bis(diphenylphosphino)acetylene (dppac) and 2-(2-pyridyl) benzimidazole 
(Hpbz) were purchased from commercial sources.  
Synthesis of Pt complexes 
[Pt(Me)Cl(DMSO)2], B 
This compound had been previously synthesized by the reaction of [PtCl2(DMSO)2] 
with SnMe4 for 24 h with a yield of 55%.24 In an alternative method, 381 mg (1.00 mmol) of 
A and 421 mg (1.00 mmol) of [PtCl2(DMSO)2] were added to 50 mL chloroform or acetone 
and stirred for 6 h.  The solvent was then removed by evaporation to give 640 mg B (1.59 
mmol). Yield: 80.0%; 1H NMR in CDCl3; trans isomer: δ 0.99 [s, 2JPtH = 78.9 Hz, 3H, Me]; 
3.42, [s, 3JPtH = 24.23 Hz, 12H, Me of DMSO]; cis isomer: δ 1.17 [s, 2JPtH = 79.0 Hz, 3H, Me]; 
3.21, [s, 3JPtH = 8.8 Hz, 6H, DMSO trans to Me]; 3.49 [s, 3JPtH = 38.2 Hz, 6H, DMSO trans to 
Cl].  
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[Pt4(Me)4(µ-dppac)2(pbz)2Cl2], 2 
 
Chart 2. NMR labeling for complex 2  
 
 [Pt(Me)Cl(DMSO)2], B, (401 mg, 1.00 mmol) was added to a solution of 1, (482 mg, 
1.00 mmol) in acetone (100 ml). This was stirred at room temperature for 24 h and then dppac 
(394 mg, 1 mmol) was added to the solution. After 20 h solvent was removed and the yellow 
residue was washed with cold diethylether to give 800 mg 2 (0.381 mmol). Yield: 76.0%; m.p. 
> 250 °C. Anal. Calc. for C80H68Cl2N6Pt4P4: C, 46.0; H, 3.2; N, 4.0 %, Found, C, 45.8; H, 3.4; 
N, 4.1%, NMR in CDCl3: δ(1H) 0.56 [d, 2JPtH = 83.5 Hz, 3JPH = 7.3 Hz, 6H, Me ligands trans 
to N of 2-pyridyl ring], 1.09 [d, 2JPtH = 72.6 Hz, 3JPH = 4.7 Hz, 6H, Me ligands trans to N of 
benzimidazole ring]; 8.15 [dd, 3JPtH = 43.6 Hz, 3JHH = 6.5 Hz, 4JPH = 5.3 Hz, 2H, H6]; 7.84 and 
7.33 [m, Ph of dppac]; 7.45 [m, H6'and H3']; 6.90 [d, 3JHH = 5.4 Hz, 2H, H3]; 6.79 [t, 3JHH = 15.2 
Hz, 2H, H5']; 6.58 [t, 3JHH = 12.7 Hz, 2H, H5]; 6.31 [t, 3JHH = 15.1 Hz, 2H, H4']; 6.07 [d, 3J(HH) 
= 8.6 Hz, 2H, H4]. δ(31P) 27.9 [s, 1JPtP = 2545 Hz, 2P, trans to benzimidazole ring], 20.6 [s, 
1JPtP = 4392 Hz, 2P, trans to Cl]. ESI-TOF-MS: m/z 2107.4 [2 + H3O]+, 1717.4 [2 – dppac + 
Na]+. 
Crystallographic data 
 Single crystal X-ray diffraction data for complex 2 were collected on a Bruker KAPPA 
APEX II diffractometer equipped with an APEX II CCD detector using a TRIUMPH 
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monochromator with a Mo Kα X-ray source (k = 0.71073 Å). The crystal was mounted on a 
cryoloop under Paratone-N oil and kept under nitrogen. Absorption correction of the data was 
carried out using the multiscan method SADABS.25 Subsequent calculations were carried out 
using SHELXTL.26 Structure determination was done using intrinsic methods. Structure 
solution, refinement, and creation of publication data was performed using SHELXTL. 
Crystallographic information is presented in Table 1. Crystallographic data for the structural 
analysis has been deposited with the Cambridge Crystallographic Data Centre, No. CCDC 
1874226. Copies of this information may be obtained free of charge from: The Director, 
CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK. Fax: +44(1223)336-033, e-mail: 
deposit@ccdc.cam.ac.uk, or www.ccdc.cam.ac.uk. 
Table 1. Crystal and structure refinement for complex 2.4(CH3)2CO. 
Empirical formula C92H92Cl2N6O4P4Pt4 
Formula weight 2320.85 
Temperature (K) 100(2) 
Wavelength(Å) 0.71073 
Crystal system Triclinic 
Space group P-1 
a/Å 11.207(3) 
b/Å 11.658(3) 
c/Å 17.085(5) 
ß/° 94.774(7) 
VolumeÅ3 2151.6(10) 
Z 1 
Density (calculated)/ Mg/m3 1.791 
Absorption coefficient/mm-1 6.672 
F(000) 1124 
Theta range for data collection 1.229 to 27.266° 
Reflections collected 18876 
Independent reflections, [R(int)] 9565, [0.0356] 
Max. and min. transmission 0.7455 and 0.5607 
Data / restraints / parameters 9565 / 0 / 511 
Goodness-of-fit on F2 0.976 
R1/wR2 [I>2sigma(I)] 0.0294/ 0.0596 
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Computational details 
Gaussian 09 was used27 to fully optimize the structure at the B3LYP level of density 
functional theory. The effective core potential of Hay and Wadt with a double-x valence basis 
set (LANL2DZ) was chosen to describe Pt.28 The 6-31G(d) basis set was used for all other 
atoms. To evaluate and ensure the optimized structures of the molecules, frequency 
calculations were carried out using analytical second derivatives. In all cases only real 
frequencies were obtained for the optimized structures. The calculations for the electronic 
absorption spectra by time-dependent DFT (TD-DFT) were performed at the same level of 
theory. The compositions of molecular orbitals and theoretical absorption spectra were plotted 
using the “Chemissian” software.29 
 
Results and Discussion 
Complex synthesis and characterization 
 The detailed synthetic route for the tetranuclear complex [Pt4(Me)4(µ-
dppac)2(pbz)2Cl2], 2, is depicted in Scheme 1. The precursor complex [Pt(Me)(DMSO)(pbz)], 
1, was prepared through the reaction of [Pt(Me)2(DMSO)2], A, with Hpbz in 1:1 ratio. In the 
key step complex B was added to a solution of 1 in acetone to produce an intermediate which 
is suggested to be the dimeric Pt complex [Cl(Me)(DMSO)Pt(µ-pbz)Pt(Me)(DMSO)], C. 
Then, dppac was added in situ to the solution to result in the assembly of 2 as a yellow solid.  
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Scheme 1. Route to preparation of complex 2 
 
 The structure of the new complex 2 was fully characterized using multinuclear NMR 
spectroscopy (1H and 31P{1H} NMR), electrospray ionization mass spectroscopy (ESI-MS) and 
X-ray crystallography. The 31P{1H} NMR spectrum is illustrated in Fig. 1A (details of the 
numerical NMR data are collected in the Experimental section). The 31P{1H} NMR spectrum 
of 2 displays two distinct singlets with equal intensities, having platinum satellites. They appear 
at δ = 20.6 (1JPtP = 4392 Hz) and 27.9 (1JPtP = 2545 Hz), which are respectively assigned to the 
P trans to Cl and the P trans to ligating N atom of benzimidazole ring, in agreement with high 
trans influence of N compared to Cl. It should be noted that the 1JPtP values of 4264 and 3081 
Hz were previously reported for P atom trans to Cl in complexes [Pt(Me)(dppe)Cl] (dppe = 
Ph2PCH2CH2PPh2) and [PtCl2(dppm)] (dppm = Ph2PCH2PPh2),30 respectively. On the basis of 
the 1H NMR spectrum of 2 (see Fig. 1B), two different Me groups are observed, being trans to 
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pyridyl and benzimidazole rings. The Me group trans to ligating N of pyridyl was observed to 
be appeared at δ = 0.56 as a doublet signal with 2JPtH = 83.5 Hz and 3JPH = 7.3 Hz. Whilst, the 
Me group trans to ligating N of benzimidazole ring was appeared at δ = 1.09 ppm with a 
considerably lower 2JPtH = 72.6 Hz and 3JPH = 4.7 Hz values. It indicates more trans influence 
of ligating N of benzimidazole ring in comparison to that for 2-pyridyl ring.  
 
Fig. 1 (A) 31P and (B) 1H (aliphatic region) NMR spectra of the complex 2. 
 
Crystal Structure 
 Yellow crystals of complex 2 were obtained upon diffusion of n-hexane vapor into the 
acetone solution. The structure obtained by X-ray crystallography technique is presented in 
Fig. 2 and the numerical data are summarized in Table 1 (see the caption of Fig. 2 for selected 
geometrical parameters). To the best of our knowledge, the complex 2 is the first example of a 
tetranuclear Pt complex having both bridging 2-(2ʹ-pyridyl)-benzimidazolate and 
bis(diphenylphosphino)acetylene ligands. In this structure, pbz ligands act as both chelating 
and bridging ligand to stabilize the tetraplatinum framework. The molecular structure of 
complex 2 certifies that the Pt4(dppac)2(pbz)2 framework was formed. As shown in Fig. 2, the 
solid state structure exhibits distorted four-coordinated square planar geometry around the 
platinum centers. The methyl groups are trans to the pyridyl and benzizmidazole rings of pbz 
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ligand. The largest deviation from ideal square planar geometry belongs to the N3-Pt2-N2 
angle at 78.01(13)° which is associated with the Pt(pbz) chelate ring. One of P atoms of dppac 
ligand is located trans to ligating N of benzimidazole ring (Pt2-P2 = 2.1910(13) Å) and another 
one is trans to Cl atom (Pt1-P1 = 2.1754(12) Å). The Me groups are located trans to the ligating 
N of the pyridyl (Pt2-C26 = 2.054(4) Å) and benzimidazole (Pt1-N1 = 2.122(3) Å) rings (See 
Fig. 2). Therefore the structure of complex 2 confirms that “Pt(µ-pbz)Pt” moieties are 
connected through dppac bridging ligand in which the P-C-C-P fragment is almost linear. The 
terminal Me ligands are transoid in relation to each other. It should be noted that this kind of 
bridged dppac complexes where a dppac molecule acts as a bridging ligand between two metal 
fragments are not common.2a, 30-31  
 
 
Fig. 2 (Top) Structure of complex 2. All hydrogen atoms and solvent molecules are omitted 
for clarity. Selected geometrical parameters (Å, deg.): Pt1-Cl1 2.3597(12); Pt1-C1 2.064(4); 
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Pt1-P1 2.1754(12); Pt1-N1 2.122(3); Pt2-N2 2.078(4); Pt2-N3 2.134(3); Pt2-P2 2.1910(13); 
Pt2-C26 2.054(4); Cl1-Pt1-N1 88.28(10); Cl1-Pt1-P1 175.11(4); Cl1-Pt1-C1 86.89(12); N1-
Pt1-P1 96.52(10); P2-Pt2-N3 104.73(10); P2-Pt2-C26 83.69(13); N3-Pt2-N2 78.01(13); N2-
Pt2-C26 93.63(16). (Bottom) 18-membered Pt4P4N4C6 central core of tetranuclear complex 2. 
 
 ESI-MS result further confirms the molecular formulae formation by demonstrated 
isotopically well-resolved peak at m/z = 2107.4 which is related to [2+H3O]+. The peak 
matched well with its calculated theoretical isotope distributions (see Fig. 3). 
 
Fig. 3 Expanded (left) and simulated (right) isotopic pattern ESI-MS spectrum of complex 
[2+H3O]+, showing the expected intensity due to isotopic distribution. 
 
Absorption spectrum 
 Complex 2 is stable in most of common organic solvents including acetone, CH2Cl2, 
CHCl3 and CH3CN which allows the investigation of its absorption spectrum in a wide range 
of solvents. Fig. 4A shows the absorption spectrum of 2 in different solvents; the numerical 
data are listed in Table 2. The complex 2 shows intense absorption bands in the 300-400 nm 
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region I all solvents. As an example, two absorption bands at 312 and 358 nm (ε = 3.00´104 
and 2.60´104 M-1 cm-1, respectively) appear in CH2Cl2 solvent. In order to gain further insight 
into the nature of electronic transitions for the complex 2 in CH2Cl2, TD-DFT calculations were 
performed on the optimized ground state geometries. As shown in Fig. 4B, the computed 
absorption wavelengths (bars) are in good agreement with its experimental spectrum. The 
numerical data for the selected calculated wavelengths together with their assignments are 
listed in Table 2. For the complex 2, the plots of molecular orbitals, the energies of the selected 
molecular orbitals together with their compositions in terms of ligands and metals are shown 
in Fig 5. The absorption bands at higher energies are attributed to L′LCT, IL and MLCT (L=pbz 
and L′= Cl).  
 
Fig. 4 (A) UV-visible absorption spectrum of complex 2 at different solvents (1.0 × 10-5 M); 
dash line shows the UV-visible spectrum of acetone, UV cutoff of acetone is 330 nm. (B) 
Overlaid experimental absorbance (spectrum) and calculated TD-DFT (bar) for the complex 2 
in CH2Cl2. 
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Table 2. TD-DFT computed spectra and experimental wavelength (nm) for the complex 2 
(1.0×10-5 M) at the ground state geometry in CH2Cl2 solution (only transitions with a 
probability higher than 20% are reported).  
λcal (f) λmax(exp) Transitions (probability) Assignments 
   (L=pbz, L′= Cl, L′′ = dppac) 
345 (0.480) 312 HOMO-3 – LUMO+1 (46) 
HOMO-2 – LUMO (35) 
L′LCT, MLCT, IL 
IL, L′LCT, MLCT 
365 (0.150) 358 HOMO – LUMO (63) 
HOMO-1 – LUMO+1 (29) 
L′LCT, MLCT 
L′LCT, MLCT 
 
 
 
Fig. 5 Representative frontier orbitals and the relative composition energy levels for complex 
2. 
 
The partial molecular orbital diagram for the tetranuclear platinum complex 2 with the several 
highest occupied and lowest unoccupied molecular orbital contours are depicted in Fig. 5 and 
the distribution of important frontier orbitals in the ground state and the corresponding partial 
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molecular orbital composition (percentages) are provided. The values of the HOMO–LUMO 
energy gap is equal to  3.588 ev. Analysis of the frontier molecular orbitals reveals that the 
maximum contribution in HOMO and HOMO-1 (the highest occupied molecular orbital) 
belongs to the Cl ligand and Pt metal center (in PtMeClNP moity) with small contribution of 
dppac ligand. In addition, the results show that LUMO and LUMO+1 (lowest unoccupied 
molecular orbitals) are significantly localized on pbz bridging ligand, and LUMO+2 is 
contributed on dppac ligand.    
 
Conclusions 
Reaction of complex [Pt(Me)(DMSO)(pbz)], in which pbz = 2-(2-pyridyl)benzimidazolate, 
with [Pt(Me)Cl(DMSO)2] in the presence of bis(diphenylphosphino)acetylene (= dppac) leads 
to a rare tetranuclear Pt(II) complex in which two 2-(2-pyridyl)-benzimidazolate ligands act as 
both chelating and bridging ligands to stabilize the tetraplatinum(II) complex. Dppac ligands 
are coordinated between Pt centers in a bridging mode via P-donor atoms, making a cyclic 
tetranuclear platinum complex. Investigation of electronic structure and related DFT and TD-
DFT calculations supported a mixed MLCT (metal-to-ligand charge transfer) and L′LCT 
(ligand-to-ligand charge transfer) and IL (Intra ligand) transition (L=pbz, and L′= Cl).  
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The computational details for complex 2. This material is available free of charge via the 
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SYNOPSIS TOC 
 
An interesting cyclic tetranuclear Pt(II) complex, 2, is synthesized by the reaction of 1 with 
[PtMe(Cl)(DMSO)2], followed by addition of dppac, bearing both the pbz (= 2-(2-
pyridyl)benzimidazolate) and the dppac (= bis(diphenylphosphino)acetylene) ligands. The 
complex is the first example in which the pbz ligands act as both chelating and bridging to 
stabilize the tetraplatinum framework.  
 
 
